RecruitingNot applicableNCT06578104
PULSED AF Post-Approval Study
Studying Hereditary atrial fibrillation
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Medtronic Cardiac Ablation Solutions
- Principal Investigator
- Khaldoun Tarakji, MDMedtronic CAS Chief Medical Officer
- Intervention
- PulseSelect™ PFA system(device)
- Eligibility
- 18 years · All sexes
- Timeline
- 2024 – 2026
Study locations (16)
- University of South Florida Health (USF), Tampa, Florida, United States
- Pikeville Medical Center, Whitesburg, Kentucky, United States
- Southcoast Health System, Fall River, Massachusetts, United States
- Beaumont Health System, Royal Oak, Michigan, United States
- Nebraska Medical Center, Omaha, Nebraska, United States
- The Valley Hospital, New York, New York, United States
- Northwell Health Lenox Hill Hospital, New York, New York, United States
- Duke University Medical Center (DUMC), Durham, North Carolina, United States
- Bethesda North Hospital, Cincinnati, Ohio, United States
- The Ohio State University Wexner Medical Center, Columbus, Ohio, United States
- Mount Carmel Grove City Medical Center, Grove City, Ohio, United States
- Doylestown Health Cardiology a division of Doylestown Health Physicians, Doylestown, Pennsylvania, United States
- AnMed Health Center, Anderson, South Carolina, United States
- Medical University of South Carolina (MUSC), Charleston, South Carolina, United States
- Texas Health Research & Education Institute, Dallas, Texas, United States
- +1 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06578104 on ClinicalTrials.govOther trials for Hereditary atrial fibrillation
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT05951101Zenith LAA Occlusion SystemAuriGen Medical Ltd
- RECRUITINGNCT05190679Prospective Phenotyping for Genetic Subtypes of Early-onset Atrial FibrillationVanderbilt University Medical Center
- RECRUITINGPHASE3NCT04045665Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGIcahn School of Medicine at Mount Sinai